Cardiovasc Prev Pharmacother > v.3(1)

3 results

1 Tafamidis for Cardiac Transthyretin Amyloidosis
Darae Kim, Jin-Oh Choi, Eun-Seok Jeon
KMSID: 1516079370   Cardiovasc Prev Pharmacother. 2021;3(1):1-9.   Published online 2021 January 31    DOI: http://dx.doi.org/10.36011/cpp.2021.3.e1
      
10 Vasopressin Receptor Antagonist, Tolvaptan, for Treating Hyponatremia in Patients with Heart Failure
Kyung-Jin Kim
KMSID: 1516079379   Cardiovasc Prev Pharmacother. 2021;3(1):10-14.   Published online 2021 January 31    DOI: http://dx.doi.org/10.36011/cpp.2021.3.e3
      
15 Methods for Evaluating the Accuracy of Diagnostic Tests
Chi-Yeon Lim
KMSID: 1516079380   Cardiovasc Prev Pharmacother. 2021;3(1):15-20.   Published online 2021 January 31    DOI: http://dx.doi.org/10.36011/cpp.2021.3.e2
      
Articles from Cardiovascular Prevention and Pharmacotherapy are provided here courtesy of Korean Society of Cardiovascular Disease Prevention; Korean Society of Cardiovascular Pharmacotherap